Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer

Hepato-Gastroenterology

Volumn 57, Issue 99-100, 2010, Pages 674-677

  Dilege, Ece ^a   Mihmanli, Mehmet ^a   Demir, Uygar ^a   Özer, Kadir ^a   Bostanci, Özgür ^a   Kaya, Cemal ^a   Aksakal, Öznur ^a   Sakiz, Damlanur ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Carbohydrate antigen 19 9; Carcinoembryonic antigen; Gastric cancer; Prognosis

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARTIAL GASTRECTOMY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TOTAL STOMACH RESECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 77955487903     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594-606.
2. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8: S4-S66.
3. Crew KD, Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-362.
4. Lauren P: The two histological main types of gastric carcinoma: diffuse and so called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
5. Gold P: Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 61965:121:439.
6. Sener SF, Imperato JP, Chmiel J, et al: The use of cancer registery data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. CA Cancer J Clin 1989;39:50-57.
7. Wichmann MW, Lau-Wernwr U, Muller C, et al: Colorectal Cancer Study Group: Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000;20:4953-4955.
8. Lai RI, Lee WJ, Huang MT, et al: Comparison of serum CA 72-4, CEA, TPA, CA 19-9 and CA 12-5 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002;49:1157-1160.
9. Mihmanli M, Dilege E, Demir U, et al: The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 2004;51:1544-1547.
10. Duraker N, Celik AN: The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001;76:266-271.
11. Choi SR, Jang JS, Lee JH: Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci 2006;51:2081-2086.
12. Kochi M, Fujii M, Kanamori N, et al: Evaluation of serum CEA and CA 19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000;3:177-186.
13. Ishigami S, Natsugoe S, Hokita S, et al: Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2002;32:41-44.
14. Gaspar MJ, Arribas I, Coca MC, et al: Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001;22:318-322.
15. Marelli D, Roviello F, De Stefano A, et al: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999;57:55-62.
16. Ojetti V, Persiani R, Cananzi F, et al: CDNA microarray analysis as a new tool to predict lymph node metastasis in gastric cancer. Dig Liver Dis 2009;41S:167.
17. Louhimo J, Kokkola A, Alfthan H, et al: Preoperative hCGβ and CA 72-4 are prognostic factors in gastric cancer. Int J Cancer 2004;111:929-933.
18. Tocchi A, Costa G, Lepre L, et al: The role of serum and gastric juice levels of carcinoembryonic antigen, CA 19-9 and CA 72-4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998;124:450-455.
19. Ucar E, Semerci E, Ustun H, et al: Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in Gastric Cancer. Adv Ther 2008;25:1075-1084.